Isoproterenol Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Embryonic Kidney Cells through Death Receptor 5 up-Regulation

Korean Circulation Journal
Young Woo EomByung-Su Yoo

Abstract

Chronic impairment of β-adrenergic receptor signaling increases cardiac apoptosis, hypertrophy and fibrosis. The aim of this study was to investigate whether isoproterenol (ISO), an agonist of the adrenergic receptor, can enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human embryonic kidney (HEK) 293 cells. HEK 293 cells were treated with ISO and/or TRAIL for 24 hours. Cell viability was evaluated by microscopy and an established viability assay, and apoptotic cell death was analyzed by staining with fluorescein isothiocynate-annexin-V/propidium iodide (PI) and caspase activation. To confirm the mechanism of cell death induced by co-treatment with ISO and TRAIL, expression of TRAIL receptor 2 (death receptor 5, DR5) was evaluated by immunoblotting. Although ISO or TRAIL treatment decreased HEK 293 cell viability by 13% and 17%, respectively, co-treatment with ISO and TRAIL resulted in a markedly higher death rate of 35% after 24 hours. Increases were evident in early apoptotic cells (i.e., annexin-V positive/PI negative; 19.4%), late apoptotic cells (i.e., annexin-V positive/PI positive; 6.3%) and dead cells (i.e., annexin-V negative/PI positive; 1.1%) when cells were co-treated wit...Continue Reading

References

Apr 20, 1999·The Journal of Experimental Medicine·T S GriffithN A Fanger
Apr 21, 1999·Current Opinion in Cell Biology·A Ashkenazi, V M Dixit
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·S EngelhardtM J Lohse
Dec 29, 2000·Journal of the American College of Cardiology·B A GroenningP R Hildebrandt
Sep 18, 2001·The Journal of Biological Chemistry·N S ChandelR H Arch
Oct 5, 2001·Trends in Genetics : TIG·S V Naga PrasadH A Rockman
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Troy J KempThomas S Griffith
Aug 24, 2004·The Journal of Biological Chemistry·Hirohito Yamaguchi, Hong-Gang Wang
Dec 24, 2005·Molecular Cancer Therapeutics·Leeona GalliganPatrick G Johnston
Jun 6, 2006·Cytokine & Growth Factor Reviews·Giorgio Zauli, Paola Secchiero
Mar 20, 2009·Nature Immunology·Nicholas S WilsonAvi Ashkenazi
Feb 13, 2010·Annual Review of Physiology·Russell S WhelanRichard N Kitsis
Oct 22, 2010·Apoptosis : an International Journal on Programmed Cell Death·Jin-Jun LiuWei-Jin Zang
May 19, 2012·Circulation Research·Steven R HouserUNKNOWN American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Function
Aug 19, 2014·Trends in Pharmacological Sciences·Sahdeo PrasadBharat B Aggarwal

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
flow cytometry

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Jinsang YooYong J Lee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Ebenezer DavidSagar Lonial
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Yuan-fang MaYou-hai Chen
© 2022 Meta ULC. All rights reserved